Life Sciences Transactions Partner Betty Yan Joins Arnold & Porter
NEW YORK, July 11, 2022—Arnold & Porter announced today the continued growth of its leading life sciences offering with the arrival of partner Betty Yan, a member of the firm’s Corporate & Finance practice. Ms. Yan has deep experience advising life sciences and technology clients, with a particular focus on transactions involving strategic alliances, joint ventures, collaborations, mergers and acquisitions, and licensing arrangements.
Richard M. Alexander, Chairman of Arnold & Porter, said: “We have continued to invest in our life sciences transactions practice in light of an active deal market and the acceleration of strategic collaborations through the industry. Betty is an experienced and well-respected practitioner in the biopharmaceutical and medical technology sectors and we have many shared clients. The arrival of Betty further distinguishes our Firm as a full-service destination for life sciences clients with transactional, regulatory and litigation needs.”
Based in New York and New Jersey, Ms. Yan represents life sciences and biotech clients in M&A and life sciences transactions. She assists clients in structuring strategic alliances, joint ventures, collaborations, and licensing arrangements, and provides counseling on issues that arise on a day to day basis for life sciences clients. She also works closely with clients preparing for clinical trial launches. Ms. Yan is experienced in drafting and negotiating industry-specific agreements including manufacture and supply agreements, research and development agreements, technology transfer agreements, and clinical trial agreements. Chambers USA notes that “Betty has excellent client service” and “can focus not only on the legal implications but also the business drivers of transactions.”
In joining Arnold & Porter, Ms. Yan said: “The firm’s integrated life sciences platform, stellar reputation, and team of terrific lawyers will allow me to continue to provide clients with exceptional service.”
Fluent in Cantonese, Ms. Yan is a former Vice President and Assistant General Counsel at JP Morgan Chase. She earned a joint JD/MBA from Fordham University.
About Arnold & Porter's Corporate and Finance Practice
Arnold & Porter’s Corporate and Finance practice serves as trusted legal advisers in business-critical transactions for clients in key industries including life sciences, financial services, technology, energy/energy transition, consumer products, and aerospace and defense, advising on mergers and acquisitions, private equity, capital markets transactions, financings, and venture capital investments, and other strategic transactions and collaborations. The practice represents corporate issuers and underwriters in registered and unregistered issuances of equity and debt; banks and non-bank lenders and borrowers in secured loan transactions; financial institutions acting in various roles in financing transactions and regulatory matters; hedge funds, private equity funds, and other investment vehicles in their formation, product development, and regulatory compliance; Fortune 500 and emerging growth companies, investors, and institutions in technology and content licensing, joint venture, and commercial transactions; and sovereign nations and sub-sovereign and quasi-governmental issuers in capital markets and financing transactions. The Corporate and Finance practice is closely integrated with other leading practice groups at the firm, thereby providing a full-service solution for our clients.
About Arnold & Porter
With nearly 1,000 lawyers practicing in 13 offices around the globe, Arnold & Porter serves clients across 40 distinct practice areas. The firm offers 100 years of renowned regulatory expertise, sophisticated litigation and transactional practices, and leading multidisciplinary offerings in the life sciences and financial services industries.
